Jagsonpal Pharmaceuticals Shareholding

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern

The Jagsonpal Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Jagsonpal Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM, BSE: 507789) operates in the sector and industry. Monitoring the Jagsonpal Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Jagsonpal Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Jagsonpal Pharmaceuticals Ltd shareholding for Mar 2026 is:

• Promoters: 67.89%
• FII: 2.44%
• DII: 0.22%
• Public: 29.45%
• Government: 0%

Promoter holding in Jagsonpal Pharmaceuticals Ltd has increased, indicating strong confidence from company promoters.

Jagsonpal Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Jagsonpal Pharmaceuticals Ltd.

• Mar 2026: 67.89%
• Dec 2025: 67.39%
• Sept 2025: 67.54%
• Jun 2025: 67.65%
• Mar 2025: 67.78%

Promoter stake in Jagsonpal Pharmaceuticals Ltd has increased, indicating strong long-term confidence.

Jagsonpal Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Jagsonpal Pharmaceuticals Ltd.

• Mar 2026: 2.44%
• Dec 2025: 2.12%
• Sept 2025: 2.12%
• Jun 2025: 2.18%
• Mar 2025: 2.10%

FII holding in Jagsonpal Pharmaceuticals Ltd has increased recently, indicating rising foreign investor interest.

Jagsonpal Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0.22%
• Dec 2025: 0.15%
• Sept 2025: 0.09%
• Jun 2025: 0.05%
• Mar 2025: 0.00%

DII stake in Jagsonpal Pharmaceuticals Ltd has increased over time, indicating growing domestic institutional confidence.

Jagsonpal Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 29.45%
• Dec 2025: 30.34%
• Sept 2025: 30.25%
• Jun 2025: 30.12%
• Mar 2025: 30.11%

Public holding remains stable with consistent retail participation.

Jagsonpal Pharmaceuticals Ltd Government Holding

Government holding in Jagsonpal Pharmaceuticals Ltd currently stands at 0%.

Jagsonpal Pharmaceuticals Ltd operates without significant government ownership.

Jagsonpal Pharmaceuticals Ltd Shareholding Analysis Summary

The Jagsonpal Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Jagsonpal Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Jagsonpal Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.